• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于测量构音障碍患者生活质量的工具的信度和效度。

Reliability and validity of an instrument to measure quality of life in the dysarthric speaker.

作者信息

Piacentini Valentina, Zuin Annalisa, Cattaneo Davide, Schindler Antonio

机构信息

Department of Clinical Sciences L. Sacco, Università degli Studi di Milano, Fondazione Don Gnocchi Onlus, IRCCS, Milan, Italy.

出版信息

Folia Phoniatr Logop. 2011;63(6):289-95. doi: 10.1159/000322800. Epub 2011 Apr 6.

DOI:10.1159/000322800
PMID:21474942
Abstract

OBJECTIVE

To develop a tool to measure quality of life (QOL) in the dysarthric speaker (QOL-DyS).

PATIENTS AND METHOD

The study consisted of two phases: scale development and item reduction (phase 1), and reliability and validity analysis (phase 2). The 100-item 'Dysarthria from the Point of View of the Dysarthric Patient' questionnaire was used for item development; the data from 50 dysarthric patients were measured for internal consistency and the 40-item QOL-DyS was developed. A second group of 50 dysarthric patients and 30 control participants were recruited for phase 2. Internal consistency and test-retest reliability were analyzed through Cronbach's α coefficient and intraclass correlation coefficient (ICC), respectively. The scores obtained from the pathological and the control group were compared using the Mann-Whitney test. Finally, the correlation between the QOL-DyS and dysarthria severity was assessed using the Spearman test.

RESULTS

An excellent internal consistency (α = 0.90) and test-retest reliability (ICC = 0.98, 95% CI: 0.97-0.99) were found; the score difference between the dysarthric and control groups was significant (p < 0.001). The QOL-DyS scores correlated positively with the severity of dysarthria (r = 0.43).

CONCLUSION

The QOL-DyS is a reliable and valid tool to assess QOL in patients with dysarthria.

摘要

目的

开发一种用于测量构音障碍患者生活质量(QOL-DyS)的工具。

患者与方法

本研究包括两个阶段:量表开发与项目缩减(第一阶段),以及信效度分析(第二阶段)。使用包含100个条目的“从构音障碍患者角度看构音障碍”问卷进行条目开发;对50名构音障碍患者的数据进行内部一致性测量,并由此开发出包含40个条目的QOL-DyS。招募了另一组50名构音障碍患者和30名对照参与者用于第二阶段研究。分别通过Cronbach's α系数和组内相关系数(ICC)分析内部一致性和重测信度。使用曼-惠特尼检验比较病理组和对照组获得的分数。最后,使用斯皮尔曼检验评估QOL-DyS与构音障碍严重程度之间的相关性。

结果

发现具有出色的内部一致性(α = 0.90)和重测信度(ICC = 0.98,95% CI:0.97 - 0.99);构音障碍组与对照组之间的分数差异具有统计学意义(p < 0.001)。QOL-DyS分数与构音障碍严重程度呈正相关(r = 0.43)。

结论

QOL-DyS是评估构音障碍患者生活质量的可靠且有效的工具。

相似文献

1
Reliability and validity of an instrument to measure quality of life in the dysarthric speaker.一种用于测量构音障碍患者生活质量的工具的信度和效度。
Folia Phoniatr Logop. 2011;63(6):289-95. doi: 10.1159/000322800. Epub 2011 Apr 6.
2
Measuring Quality of Life in the Speaker with Dysarthria: Reliability and Validity of the European Portuguese Version of the QoL-DyS.
Folia Phoniatr Logop. 2019;71(4):176-190. doi: 10.1159/000495564. Epub 2019 Apr 17.
3
Relationship between quality of life and dysarthria in patients with multiple sclerosis.多发性硬化症患者生活质量与构音障碍之间的关系。
Arch Phys Med Rehabil. 2014 Nov;95(11):2047-54. doi: 10.1016/j.apmr.2014.04.023. Epub 2014 May 14.
4
Quality of life instrument for Turkish people with skin diseases.土耳其皮肤病患者生活质量量表
Int J Dermatol. 2005 Nov;44(11):933-8. doi: 10.1111/j.1365-4632.2004.02225.x.
5
[The development and Assessment on the general quality of life intrument for Chinese people].[中国人生活质量综合评定量表的编制与考评]
Zhonghua Liu Xing Bing Xue Za Zhi. 2005 Oct;26(10):751-6.
6
Development and validation of NEWSQOL, the Newcastle Stroke-Specific Quality of Life Measure.纽卡斯尔卒中特异性生活质量量表(NEWSQOL)的开发与验证
Cerebrovasc Dis. 2004;17(2-3):143-52. doi: 10.1159/000075783. Epub 2003 Dec 23.
7
Development and validation of a disease-specific quality of life questionnaire for gastro-oesophageal reflux disease: the GERD-QOL questionnaire.开发和验证一种用于胃食管反流病的疾病特异性生活质量问卷:胃食管反流病生活质量问卷(GERD-QOL 问卷)。
Aliment Pharmacol Ther. 2010 Feb 1;31(3):452-60. doi: 10.1111/j.1365-2036.2009.04187.x. Epub 2009 Oct 31.
8
Outcomes and patient-based hearing status in conductive hearing loss.传导性听力损失的治疗结果及基于患者的听力状况
Laryngoscope. 2001 Nov;111(11 Pt 2 Suppl 98):1-21. doi: 10.1002/lary.5541111401.
9
Linguistic validation of the Irritable Bowel Syndrome-Quality of Life Questionnaire for Iranian patients.肠易激综合征生活质量问卷对伊朗患者的语言验证
Acta Med Iran. 2011;49(6):390-5.
10
[Validation of a self assessment for speech disorders (Phonation Handicap Index)].[言语障碍自我评估(发声障碍指数)的验证]
Rev Laryngol Otol Rhinol (Bord). 2009;130(1):45-51.

引用本文的文献

1
How do we measure dysarthria after stroke? A systematic review to guide the core outcome set for dysarthria.中风后我们如何测量构音障碍?一项指导构音障碍核心结局集的系统评价。
BMJ Open. 2025 May 23;15(5):e099662. doi: 10.1136/bmjopen-2025-099662.
2
Comparing face-to-face and online LSVT®LOUD speech training using LSVT®Coach in patients with Parkinson's disease: a pilot randomised controlled trial.使用LSVT®Coach对帕金森病患者进行面对面和在线LSVT®LOUD言语训练的比较:一项试点随机对照试验。
BMC Neurol. 2025 Apr 26;25(1):183. doi: 10.1186/s12883-025-04161-0.
3
Intensive Speech Therapy for Hypokinetic Dysarthria in Parkinson's Disease: Targeting the Five Subsystems of Speech Production with Clinical and Instrumental Evaluation.
帕金森病运动减少型构音障碍的强化言语治疗:通过临床和仪器评估针对言语产生的五个子系统
NeuroSci. 2025 Jan 16;6(1):7. doi: 10.3390/neurosci6010007.
4
Efficacy and feasibility of a digital speech therapy for post-stroke dysarthria: protocol for a randomized controlled trial.一种针对中风后构音障碍的数字言语治疗的疗效和可行性:一项随机对照试验方案
Front Neurol. 2024 Jan 31;15:1305297. doi: 10.3389/fneur.2024.1305297. eCollection 2024.
5
Further development in measuring communicative participation: identifying items to extend the applicability of the communicative participation item bank.进一步发展沟通参与的测量:确定项目以扩展沟通参与项目库的适用性。
J Patient Rep Outcomes. 2023 May 26;7(1):49. doi: 10.1186/s41687-023-00586-8.
6
Patient reported outcomes for phosphomannomutase 2 congenital disorder of glycosylation (PMM2-CDG): listening to what matters for the patients and health professionals.磷酸甘露糖变位酶 2 先天性糖基化障碍(PMM2-CDG)患者报告结局:倾听患者和医疗保健专业人员的心声。
Orphanet J Rare Dis. 2022 Oct 29;17(1):398. doi: 10.1186/s13023-022-02551-y.
7
Multidimensional voice assessment after Lee Silverman Voice Therapy (LSVT) in Parkinson's disease.帕金森病行李·西尔曼嗓音治疗(LSVT)后的多维嗓音评估。
Acta Otorhinolaryngol Ital. 2022 Aug;42(4):348-354. doi: 10.14639/0392-100X-N1962.
8
Psychometrics, diagnostics and usability of Italian tools assessing behavioural and functional outcomes in neurological, geriatric and psychiatric disorders: a systematic review.心理计量学、诊断学以及意大利工具在神经、老年和精神障碍中的行为和功能结果评估的可用性:系统评价。
Neurol Sci. 2022 Nov;43(11):6189-6214. doi: 10.1007/s10072-022-06300-8. Epub 2022 Aug 6.
9
Speech-Language Pathology Evaluation and Management of Hyperkinetic Disorders Affecting Speech and Swallowing Function.影响言语和吞咽功能的多动障碍的言语语言病理学评估与管理
Tremor Other Hyperkinet Mov (N Y). 2017 Sep 21;7:489. doi: 10.7916/D8Z32B30. eCollection 2017.